Mustang Bio
MBIO
79 hedge funds and large institutions have $71.8M invested in Mustang Bio in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 19 closing their positions.
74% more call options, than puts
Call options by funds: $1.19M | Put options by funds: $685K
12% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 25
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
14% less funds holding
Funds holding: 92 → 79 (-13)
16% less capital invested
Capital invested by funds: $85.9M → $71.8M (-$14.1M)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.35M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.27M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.2M |
| 4 |
JP Morgan Chase
New York
|
+$924K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$866K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.19M |
| 2 |
Two Sigma Investments
New York
|
-$1.13M |
| 3 |
Two Sigma Advisers
New York
|
-$561K |
| 4 |
VF
Virtu Financial
New York
|
-$389K |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$348K |
MBIO Hedge Fund Activity: Q3 2021 in Review
79 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2021, worth a combined $71.8M — down 16% from $85.9M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of MBIO and 7 opened new positions — a net loss of 12 holders — while 25 trimmed existing stakes and 28 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.35M. The largest seller was Dimensional Fund Advisors, cutting an estimated $1.19M.
- 79 institutional investors held Mustang Bio (MBIO) as of Q3 2021, down from 92 in Q2 2021.
- Funds reported $71.8M of Mustang Bio stock for Q3 2021, down 16% quarter-over-quarter.
- 7 funds opened new Mustang Bio positions in Q3 2021 and 19 closed out, a net change of -12 holders.
- The largest Mustang Bio buyer in Q3 2021 was Renaissance Technologies, an estimated $1.35M added.
- The largest Mustang Bio seller in Q3 2021 was Dimensional Fund Advisors, an estimated $1.19M sold.
Based on aggregated 13F filings for Q3 2021.